| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Bulk Supply Fine Chemicals Raw Material Powder Linagliptin CAS 668270-12-0
Functions
Linagliptin Linagliptin, developed by Boehringer Ingelheim, was approved by the FDA on May 2, 2011. It is used in combination with diet and exercise to improve the control of blood glucose levels in people with type 2 diabetes. Linagliptin improves blood glucose control in patients by inhibiting dipeptidyl peptidase-4 (DPP-4).
|
Product name
|
CAS No.
|
|
β-Nicotinamide Mononucleotide (NMN)
|
1094-61-7
|
|
beta-Diphosphopyridine nucleotide (NAD)
|
53-84-9
|
|
Nicotinamide riboside chloride (NRC)
|
23111-00-4
|
|
Nicotinamide Ribose (NR)
|
1341-23-7
|
|
|
53-43
|
Extraction process:
){kind=link}